Assignee
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL
GB·20 granted patents·17 pending applications·16 citations·filing 2013–2025
Top patents by PatentIndex Score
37 records- 0191US11517573B2Therapeutic compositions, combinations, and methods of useTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2021·Granted Dec 6, 2022·3 cites·12 claims
- 0288US10995088B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2020·Granted May 4, 2021·2 cites·22 claims
- 0386US11400090B2Coumarin derivative for therapy or prophylaxis of a cell proliferative disorderTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2018·Granted Aug 2, 2022·3 cites·15 claims
- 0481US2024245643A1DNA Damage Repair Inhibitors for Treatment of CancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2023·Application pending·0 cites
- 0580US12280050B2Therapeutic compositions, combinations, and methods of useTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2024·Granted Apr 22, 2025·0 cites·26 claims
- 0680US10807974B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2017·Granted Oct 20, 2020·2 cites·35 claims
- 0776US12189010B2Diffusion-weighted magnetic resonance imagingTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2020·Granted Jan 7, 2025·2 cites·11 claims
- 0875US2025345331A1Coumarin derivative for therapy or prophylaxis of a cell proliferative disorderTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2025·Application pending·0 cites
- 0974US2023277535A1Therapeutic compositions, combinations, and methods of useTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2022·Application pending·0 cites
- 1073US12390465B2Coumarin derivative for therapy or prophylaxis of a cell proliferative disorderTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2022·Granted Aug 19, 2025·0 cites·21 claims
- 1173US11325915B2Lysyl oxidase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2018·Granted May 10, 2022·1 cites·18 claims
- 1272US2026034128A1Therapeutic compositions, combinations, and methods of useTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2025·Application pending·0 cites
- 1372US2021244706A1DNA Damage Repair Inhibitors for Treatment of CancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2020·Application pending·0 cites
- 1470US11393654B2X-ray micro-beam production and high brilliance x-ray productionTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2017·Granted Jul 19, 2022·3 cites·14 claims
- 1565US11608330B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2021·Granted Mar 21, 2023·0 cites·34 claims
- 1664US12060360B2Lysyl oxidase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2022·Granted Aug 13, 2024·0 cites·16 claims
- 1764US11594394B2X-ray micro-beam production and high brilliance x-ray productionTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2022·Granted Feb 28, 2023·0 cites·8 claims
- 1864US2020216818A1Vaccinia virus for gene-directed enzyme prodrug therapyTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2019·Application pending·0 cites
- 1958US2025290147A1Prostate cancer markersTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2023·Application pending·0 cites
- 2057US2023173048A1Anti-cancer vaccines and related therapyTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2021·Application pending·0 cites
- 2151US2025265706A1Delineation of One or More Parts of a Body Within a Diffusion Weighted MRI ImageTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2023·Application pending·0 cites
- 2251US2025263799A1Methods of treating cancer using replication stress modulatorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2023·Application pending·0 cites
- 2345US2022218708A1Methods for treating smarcb1 deficient cancer or pazopanib resistant cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2017·Application pending·0 cites
- 2444US10885679B2Method for producing a weighted magnetic resonance imageTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2017·Granted Jan 5, 2021·0 cites·13 claims
- 2543US2022017516A1Lox inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2019·Application pending·0 cites
- 2640US12233060B2Inhibitors of Ataxia-Telangiectasia Mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2017·Granted Feb 25, 2025·0 cites·9 claims
- 2740US12018029B2Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2019·Granted Jun 25, 2024·0 cites·19 claims
- 2840US10674920B2Ultrasonic imagingTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2013·Granted Jun 9, 2020·0 cites·26 claims
- 2940US2024052420A1Treatment response predictive methodTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2021·Application pending·0 cites
- 3040US2023348990A1Prognostic and treatment response predictive methodTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2021·Application pending·0 cites
- 3139US12421556B2Materials and methods for stratifying and treating cancersTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2018·Granted Sep 23, 2025·0 cites·16 claims
- 3238US12561993B2Analysis of histopathology samplesTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2022·Granted Feb 24, 2026·0 cites·20 claims
- 3337US11788148B2Prognostic and treatment response predictive methodTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2018·Granted Oct 17, 2023·0 cites·1 claims
- 3437US2020171032A1Methods and medical usesTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2018·Application pending·0 cites
- 3534US2018112258A1Medical uses and methods for treating cancer using monopolar spindle 1 (mps1) kinase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2016·Application pending·0 cites
- 3630US2021102260A1Patient classification and prognositic methodTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2019·Application pending·0 cites
- 3728US10346973B2Scoring of tumor infiltration by lymphocytesTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2015·Granted Jul 9, 2019·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →